David N Alter
Overview
Explore the profile of David N Alter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flippo A, Dixit B, Schukow C, Hacking S, Song L, Fiock K, et al.
Acad Pathol
. 2024 Nov;
11(4):100151.
PMID: 39559455
The use of social media platforms in pathology and medical laboratory science has increased in recent years, revolutionizing the way professionals in these fields interact, disseminate information, and collaborate. To...
2.
Haddad N, Morrison-Porter A, Quehl H, Capric V, Lamothe P, Anam F, et al.
medRxiv
. 2024 Jul;
PMID: 39006446
Post-acute sequelae of SARS-CoV-2 (SARS2) infection (PASC) is a heterogeneous condition, but the main viral drivers are unknown. Here, we use MENSA, Media Enriched with Newly Synthesized Antibodies, secreted exclusively...
3.
Cheedarla N, Verkerke H, Potlapalli S, McLendon K, Patel A, Frank F, et al.
iScience
. 2023 Nov;
26(11):108256.
PMID: 37965140
Traditional cellular and live-virus methods for detection of SARS-CoV-2 neutralizing antibodies (nAbs) are labor- and time-intensive, and thus not suited for routine use in the clinical lab to predict vaccine...
4.
Guarner J, Smith G, Alter D, Williams C, Cole L, Campbell D, et al.
Arch Pathol Lab Med
. 2023 Oct;
148(4):e69-e74.
PMID: 37852173
Context.—: Urinalysis instrument-specific dip strips offer physicians qualitative results for actionable analytes (protein, glucose, leukocyte esterase, nitrates, hemoglobin, and ketones). Objective.—: To explain a strategy implemented to support clinical decision-making...
5.
Tedbury P, Manfredi C, Degenhardt F, Conway J, Horwath M, McCracken C, et al.
FASEB J
. 2023 Oct;
37(11):e23220.
PMID: 37801035
Patients with cystic fibrosis (CF) exhibit pronounced respiratory damage and were initially considered among those at highest risk for serious harm from SARS-CoV-2 infection. Numerous clinical studies have subsequently reported...
6.
7.
8.
Attieh M, Dent E, Happney L, Roback J, Alter D, Barrette E, et al.
Transfusion
. 2023 Feb;
63(4):888-892.
PMID: 36794568
Background: Platelet-transfusion refractory (PR) patients do not achieve expected post-transfusion platelet counts. We investigate suspected PR patients with post-transfusion platelet counts, indirect platelet antibody screens (ind-PAS), Class I HLA antibody...
9.
10.
Cheedarla N, Verkerke H, Potlapalli S, McLendon K, Patel A, Frank F, et al.
Res Sq
. 2022 Feb;
PMID: 35194599
Traditional cellular and live-virus methods for detection of SARS-CoV-2 neutralizing antibodies (nAbs) are labor- and time-intensive, and thus not suited for routine use in the clinical lab to predict vaccine...